MedPath

Clinical Outcome in patient with cerebral vasospasm after aneurysmal subarachnoid hemorrhage treated with intra-arterial Nimodipine infusion: A Randomized Controlled Trial

Phase 2
Completed
Conditions
Aneurysmal subarachnoid hemorrhageCerebral Vasospasm
aneurysm
vasospasm
intra&#45
arterial
nimodipine
Registration Number
TCTR20200121002
Lead Sponsor
one
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
68
Inclusion Criteria

ASAH patients, ranging in age 18 - 80 years, on whom aneurysm obliteration was performed, either by surgical clipping or endovascular therapy
After aneurysm obliteration, digital subtraction diagnostic angiography was performed on all patients. If angiographic vasospasm was demonstrated, we enrolled the patients, whether or not they suffered any clinical vasospasm, such as alteration of consciousness, new motor deficits, or unexplained fever. Consent was informed and obtained from the patients or their relatives, as appropriate
Every angiography was done within 14 days, according to the date of rupture, otherwise the case was excluded. After we found any angiographic vasospasm (defined as any acute tapering or focal vasoconstriction of any vessels compared to prior diagnostic imaging), we categorized patients into good neurological baseline group, defined as World Federation of Neurological Surgeons’ score (WFNS) grade I-III, and poor neurological baseline group defined as WFNS grade IV-V first, and then performing block randomization into 1:1 of the intervention and control groups

Exclusion Criteria

No angiographic vasospasm
Angiography done after 14 days
Denied consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
eurological Outcome 6 months after intervention WFNS, Glasgow Coma Scale (GCS), and motor power, Glasgow Outcome Scale (GOS), modified Rankin Scale
Secondary Outcome Measures
NameTimeMethod
Angiographic outcome After intervention caliber of vessels suspected of vasospasm
© Copyright 2025. All Rights Reserved by MedPath